Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics

Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics

Saved in:

Bibliographic Details
Main Authors:	Michael E. Wechsler, Linda Rogers, G. Walter Canonica, Arnaud Bourdin, Arman Altincatal, Megan Hardin, Xavier Soler, Paul J. Rowe, Yamo Deniz, Harry Sacks, Juby A. Jacob-Nara
Format:	Article
Language:	English
Published:	European Respiratory Society 2024-12-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/10/6/00188-2024.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Moving to lower-poverty neighborhoods offers broad benefits for children with asthma, regardless of sex or other baseline characteristics
by: Torie L. Grant, MD, MHS, et al.
Published: (2025-05-01)

Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan
by: Makoto Nagata, et al.
Published: (2025-01-01)

Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma
by: Kenji Mizumura, et al.
Published: (2025-01-01)

Successful treatment of Kimura’s disease with dupilumab and review of dupilumab in treating eosinophilic dermatoses
by: Yunhong Zheng, et al.
Published: (2025-12-01)

INTERNATIONAL COOPERATION OF NNGASU - THE PROJECTS REGARDLESS OF TIME AND POLITICS
by: Yuriy V. Philippov
Published: (2016-12-01)

One approach is that we learn together, regardless of the language, regardless of the school subject: the translanguaging stance of teachers in a migration school scenario in southern Brazil
by: Anamaria Welp, et al.
Published: (2025-01-01)

Extended-release amphetamine (Dyanavel XR) is associated with reduced immediate-release supplementation in adults with ADHD, regardless of baseline patient variables: a retrospective cohort analysis of medical treatment records
by: Joel L. Young, et al.
Published: (2025-01-01)

Eosinophilic Gastritis in a Patient Previously Treated with Dupilumab
by: Masaya Iwamuro, et al.
Published: (2020-01-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01)

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis
by: Seiichiro Kamimura, et al.
Published: (2025-03-01)

Digital connection, real bonding: Brief online chats boost interpersonal closeness regardless of the conversational topic
by: Chiara Fini, et al.
Published: (2025-02-01)

IL18 Polymorphism and Periodontitis Susceptibility, Regardless of IL12B, MMP9, and Smoking Habits
by: Patrícia Yumeko Tsuneto, et al.
Published: (2019-01-01)

Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
by: C. Grote, et al.
Published: (2025-12-01)

Case report: Dupilumab-induced linear psoriasis: a rare presentation
by: Wen Sun, et al.
Published: (2025-01-01)

Dupilumab-induced serum sickness-like reaction in a pediatric patient
by: S. Minhaj Rahman, BA, et al.
Published: (2025-02-01)

Non-Completely Displaced Traumatic Rib Fractures: Potentially Less Crucial for Pulmonary Adverse Outcomes, Regardless of Classification
by: Hongrye Kim, et al.
Published: (2025-01-01)

Acute particulate matter exposure diminishes executive cognitive functioning after four hours regardless of inhalation pathway
by: Thomas Faherty, et al.
Published: (2025-02-01)

Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic Dermatitis
by: Niccolò Gori, et al.
Published: (2024-01-01)

Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
by: Nicola Lutzu, et al.
Published: (2025-01-01)

Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review
by: Feiying Guo, et al.
Published: (2025-02-01)

Efficacy and safety of dupilumab in a patient with metastatic clear cell renal cell carcinoma
by: César Ferreira, et al.
Published: (2024-11-01)

Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis
by: Verónica Sánchez-García, et al.
Published: (2025-02-01)

Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps
by: Shaun J. Kilty, et al.
Published: (2022-04-01)

The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
by: Nicholas J. Campion, et al.
Published: (2023-09-01)

Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency
by: Sophia Trombello, et al.
Published: (2025-01-01)

Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
by: Simbarashe Takuva, et al.
Published: (2013-01-01)

Medial Patellofemoral Ligament Repair with Suture Tape Augmentation Can Yield Good Midterm Clinical Outcomes Regardless of Skeletal Maturity and Joint Laxity
by: Shinichiro Takada, et al.
Published: (2025-01-01)

Long-Baseline Neutrino Oscillation Experiments
by: G. J. Feldman, et al.
Published: (2013-01-01)

Is the Increase in Tumour Markers and Hashimoto’s Thyroiditis an Incidental Event During Dupilumab Treatment? A Case Report
by: Kesheng Lin, et al.
Published: (2025-02-01)

Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission
by: Mona Al-Ahmad, MD, FRCPC, et al.
Published: (2025-02-01)

Dupilumab-induced psoriasis in a patient with atopic dermatitis successfully treated with Upadacitinib: A case report
by: Katrina D Cirone, et al.
Published: (2025-02-01)

Borg’s category ratio-scale (CR-10) is useful to predict the onset of blood lactate accumulation (OBLA) in young Mexicans adults, regardless their body mass
by: Arnulfo Ramos Jiménez, et al.
Published: (2019-01-01)

Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study
by: Yanhua Chen, et al.
Published: (2025-01-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

An Appraisal of Muon Neutrino Disappearance at Short Baseline
by: L. Stanco, et al.
Published: (2013-01-01)

Turned stem tension band technique in reverse total shoulder arthroplasty for proximal humeral fracture can achieve high tuberosity healing rates regardless of the vertical sutures
by: Kazumasa Takayama, MD, et al.
Published: (2025-01-01)

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01)

Severe atopic dermatitis treated with Dupilumab in a CTLA-4-deficient patient: A case report and review of the literature
by: Ye-Jean Park, et al.
Published: (2025-01-01)